T. Rowe Price Associates
CMLFU

T. Rowe Price Associates’s CM Life Sciences, Inc. Unit CMLFU Stock Holding History

T. Rowe Price Associates’s Portfolio CMLFU Stock Details CMLFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,090,987
Closed -$34.2M – 3033
2021
Q2 		$34.2M Sell
2,090,987
-56,867
-3% -$823K ﹤0.01% 1162
2021
Q1 		$35.3M Hold
2,147,854
– – ﹤0.01% 1128
2020
Q4 		$24.9M Hold
2,147,854
– – ﹤0.01% 1167
2020
Q3 		$22.5M Buy
+2,147,854
New +$22.6M ﹤0.01% 1121

T. Rowe Price Associates's CMLFU Position: Q3 2021 in Review

T. Rowe Price Associates sold out of CM Life Sciences, Inc. Unit (CMLFU) in Q3 2021, closing a stake of 2,090,987 shares — an estimated $34.2M sold.

T. Rowe Price Associates first reported a position in CMLFU in Q3 2020 and held it in 4 quarters. The position peaked at $35.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMLFU as of Q3 2021.

  • T. Rowe Price Associates reported no remaining CM Life Sciences, Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 2,090,987 CM Life Sciences, Inc. Unit shares in Q3 2021, an estimated $34.2M.
  • T. Rowe Price Associates first reported a position in CM Life Sciences, Inc. Unit in Q3 2020 and held it in 4 quarters.
  • T. Rowe Price Associates's CM Life Sciences, Inc. Unit position peaked at $35.3M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences, Inc. Unit as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.